• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 1127

Lactiplantibacillus plantarum ATCC-202195

Intended Use: Intended for use in non-exempt cow milk- or soy-based infant formula for term infants, non-exempt partially hydrolyzed cow milk-based infant formula for term infants, exempt extensively hydrolyzed cow milk-based infant formula for term infants, and formula for young children (> 12 months) at a level up to 108 colony forming units (CFU)/g of powdered formula; in juices and drinks, cereal and grain products, and fruit and vegetable purees for infants and young children at 2 x 1010 CFU/serving; and in flavored milk beverages, dairy and non-dairy yogurt and smoothies, soy products, powdered meal replacement beverages, fruit juices and nectars, fruit-based beverages, candy, and cereal and nutrition bars at 2 x 1010 CFU/serving.
Basis: Scientific procedures
Notifier: Danisco USA, Inc.
Notifier Address: DuPont Experimental Station
E353 200 Powder Mill Road
Wilmington, DE 19803
GRAS Notice (releasable information): GRN 1127 with amendments (in PDF) (7.6 MB)
Date of closure: Feb 1, 2024
FDA's Letter: FDA has no questions (in PDF) (235 kB)